Nociceptin/orphanin FQ and drugs of abuse

被引:85
作者
Ciccocioppo, R [1 ]
Angeletti, S
Panocka, I
Massi, M
机构
[1] Univ Camerino, Dept Pharmacol Sci & Expt Med, I-62032 Camerino, Italy
[2] Mil Hyg & Epidemiol, Dept Pharmacol & Toxicol, PL-01163 Warsaw, Poland
关键词
nociceptin; orphanin FQ; ORL1; receptors; opioids; brain reward system; drug abuse; reward; reinforcement;
D O I
10.1016/S0196-9781(00)00245-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nociceptin/orphanin FQ (NC) binds with high affinity to the opioid receptor-like 1 (ORL1) receptor. NC has been reported to block opioid-induced supraspinal analgesia, and it has been proposed that it may represent a functional antiopioid peptide in the control of brain nociceptive processes. The wide distribution of NC and of its receptors in the central nervous system suggests, however, that it may be involved in the control of a variety of biologic functions. Increasing evidence indicates that it may influence the rewarding and reinforcing properties of drugs of abuse. NC has been shown to abolish the rewarding properties of ethanol and morphine in the place conditioning paradigm, to reduce ethanol consumption in alcohol-preferring rats and to inhibit stress-induced alcohol-seeking behavior. These findings suggest that drugs directed at central NC receptors may represent an interesting approach to the treatment of ethanol and opiate abuse. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1071 / 1080
页数:10
相关论文
共 117 条
[1]   BLOCKADE OF ACQUISITION OF DRUG-CONDITIONED PLACE AVERSION BY 5HT3 ANTAGONISTS [J].
ACQUAS, E ;
CARBONI, E ;
GARAU, L ;
DICHIARA, G .
PSYCHOPHARMACOLOGY, 1990, 100 (04) :459-463
[2]   The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide [J].
Ågmo, A ;
Belzung, C .
NEUROPHARMACOLOGY, 1998, 37 (02) :223-232
[3]  
ANGELETTI S, 1999, REGUL PEPTIDES, V80, P122
[4]  
Anton B, 1996, J COMP NEUROL, V368, P229
[5]   Functional heterogeneity in dopamine release and in the expression of Fos-like proteins within the rat striatal complex [J].
Barrot, M ;
Marinelli, M ;
Abrous, DN ;
Rougé-Pont, F ;
Le Moal, M ;
Piazza, PV .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (04) :1155-1166
[6]   What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? [J].
Berridge, KC ;
Robinson, TE .
BRAIN RESEARCH REVIEWS, 1998, 28 (03) :309-369
[7]   Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice [J].
Bespalov, AY ;
Tokarz, ME ;
Bowen, SE ;
Balster, RL ;
Beardsley, PM .
PSYCHOPHARMACOLOGY, 1999, 141 (02) :118-122
[8]   RELATIONSHIP BETWEEN DOPAMINE RELEASE IN NUCLEUS-ACCUMBENS AND PLACE PREFERENCE INDUCED BY SUBSTANCE-P INJECTED INTO THE NUCLEUS BASALIS MAGNOCELLULARIS REGION [J].
BOIX, F ;
SANDOR, P ;
NOGUEIRA, PJC ;
HUSTON, JP ;
SCHWARTING, RKW .
NEUROSCIENCE, 1995, 64 (04) :1045-1055
[9]   D-3 receptor test in vitro predicts decreased cocaine self-administration in rats [J].
Caine, SB ;
Koob, GF ;
Parsons, LH ;
Everitt, BJ ;
Schwartz, JC ;
Sokoloff, P .
NEUROREPORT, 1997, 8 (9-10) :2373-2377
[10]  
CAINE SB, 1994, J PHARMACOL EXP THER, V270, P209